MENU
XERS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Xeris Biopharma Holdings (XERS) Earnings Date & Reports

A.I. Advisor
published Earnings

XERS is expected to report earnings to fall 28.82% to -7 cents per share on March 05

Xeris Biopharma Holdings XERS Stock Earnings Reports
Q4'24
Est.
$-0.08
Q3'24
Missed
by $0.02
Q2'24
Est.
$-0.10
Q1'24
Missed
by $0.04
Q4'23
Missed
by $0.01
The last earnings report on November 08 showed earnings per share of -10 cents, missing the estimate of -9 cents. With 1.48M shares outstanding, the current market capitalization sits at 454.70M.
View a ticker or compare two or three
XERS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of ready-to-use, liquid-stable injectables

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1375 West Fulton Street
Phone
+1 844 445-5704
Employees
377
Web
https://www.xerispharma.com